| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8594242 | Journal of Stroke and Cerebrovascular Diseases | 2018 | 6 Pages |
Abstract
There is insufficient evidence regarding cases for which DOACs would be suitable for the prevention of thromboembolism and regarding its long-term efficacy and safety in patients with cancer. As it stands, heparin treatment, which has multifaceted antithrombotic actions, may be suitable for cancer-associated stroke prevention.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Hiroyuki MD, Tomohisa MD, PhD, Naohisa MD, PhD, Shiro MD, PhD, Hiroki MD, PhD, Kazuhide MD, PhD, Hirofumi MD, PhD,